E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/11/2006 in the Prospect News Biotech Daily.

New Issue: ART Advanced Research Technologies prices C$7 million stock sale at C$0.75

New York, May 11 - ART Advanced Research Technologies Inc. said it priced a C$7 million offering of common shares at C$0.75 per share.

The company sold a total of 9,333,600 shares and there is a greenshoe for a further 3,200,000.

Salman Partners Inc. led the sale, which was offered by prospectus in Canada. The shares are not registered for sale in the United States. Canaccord Capital Corp. and Westwind Partners Inc. were co-managers.

ART Advanced Research Technologies is a Montreal-based maker of medical devices and optical molecular imaging products.

Issuer:ART Advanced Research Technologies Inc.
Issue:Follow-on sale of common shares
Amount:C$7,000,500
Shares:9,333,600
Greenshoe:3,200,000
Price:C$0.75
Warrants:No
Lead manager:Salman Partners Inc.
Pricing date:May 10
Settlement:May 17
Stock ticker:TSX: ARA
Stock price:C$0.84 at close May 10

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.